Stay updated on INOXT for ASD Clinical Trial
Sign up to get notified when there's something new on the INOXT for ASD Clinical Trial page.
Latest updates to the INOXT for ASD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedOntario and other locations are now listed under Locations (Hamilton and Toronto), clarifying where the study is being conducted. The HHS Vulnerability Disclosure link and the older Ontario Locations entry were removed.SummaryDifference0.2%
- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check54 days agoChange DetectedThe notice about government funding/operating status was removed from the page, while the study details, eligibility criteria, and contact information remain unchanged.SummaryDifference0.4%
- Check75 days agoChange DetectedNo core study content changes detected; the differences appear to be cosmetic and do not alter the study's title, conditions, eligibility criteria, locations, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check97 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference4%
- Check104 days agoChange DetectedPage now shows a new version (v3.1.0) and removes multiple drug-safety subtopics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating a content narrowing or reorganization.SummaryDifference0.5%
Stay in the know with updates to INOXT for ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INOXT for ASD Clinical Trial page.